Skandinaviska Enskilda Banken (SEB)
MDCO

Skandinaviska Enskilda Banken (SEB)’s Medicines Co MDCO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-199,792
Closed -$17M – 976
2019
Q4 		$17M Buy
+199,792
New +$13.3M 0.13% 150

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Skandinaviska Enskilda Banken (SEB)'s MDCO Position: Q1 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 199,792 shares — an estimated $17M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $17M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 199,792 Medicines Co shares in Q1 2020, an estimated $17M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Medicines Co position peaked at $17M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2020, filed 13 May 2020.